RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Tanmoy Mondal to Drug Screening Assays, Antitumor

Back to Details
This is a "connection" page, showing publications Tanmoy Mondal has written about Drug Screening Assays, Antitumor.
Tanmoy Mondal
Connection Strength
0.454
Drug Screening Assays, Antitumor
  1. Satti VR, Raza MS, Roshani K, Veeranki KC, Mondal T. Design and Synthesis of Novel Indazole-Sulfonamide Derivatives, Cytotoxicity, and Molecular Docking Insights. Chem Biodivers. 2026 Feb; 23(2):e03697.
    View in: PubMed
    Score: 0.231
  2. Mondal T, Sahoo P, Nandi SK, Kundu S, Li M, Haldar N, Kabir R, Mitra K, Roy S, Das M, Ghosh CK. Opto-magnetic optimization enhances the multimodal therapeutic and diagnostic (UCL/T1-T2W MRI) potential of GdOF against MDA-MB-231. J Mater Chem B. 2025 Aug 13; 13(32):9993-10008.
    View in: PubMed
    Score: 0.223
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support